ConductScience.org, home

Paper40698129

Unraveling the therapeutic landscape of approved non-peptide macrocycles.

Li Z and 2 others. Acta Pharm Sin B, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Unraveling the therapeutic landscape of approved non-peptide macrocycles. Papers, record 40698129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40698129

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unraveling the therapeutic landscape of approved non-peptide macrocycles.
PubMed
Journal
Acta Pharm Sin B
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.13, provisional
iCite
Revised in PubMed
2025-07-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li ZZhonghua
2Zhang ZZhenqiang
3Yu BBin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References183

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121923589Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.Pharmacotherapy2011https://conductscience.org/library/papers/21923589PubMed
229249240Recent advances in the synthesis of cyclic pseudopeptides.Drug Discov Today Technol2017https://conductscience.org/library/papers/29249240PubMed
314709862Recent developments in the maytansinoid antitumor agents.Chem Pharm Bull (Tokyo)2004https://conductscience.org/library/papers/14709862PubMed
433207094First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.N Engl J Med2020https://conductscience.org/library/papers/33207094PubMed
520104527Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.Int J Cancer2010https://conductscience.org/library/papers/20104527PubMed
638179950Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?J Med Chem2024https://conductscience.org/library/papers/38179950PubMed
732309620FDA approved antibacterial drugs: 2018-2019.Discoveries (Craiova)2019https://conductscience.org/library/papers/32309620PubMed
832764876Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy.Drug Des Devel Ther2020https://conductscience.org/library/papers/32764876PubMed
938279972Repotrectinib: First Approval.Drugs2024https://conductscience.org/library/papers/38279972PubMed
1026464510Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26464510PubMed
1128077299Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers.Pharmacol Res2017https://conductscience.org/library/papers/28077299PubMed
1223636326mTOR kinase structure, mechanism and regulation.Nature2013https://conductscience.org/library/papers/23636326PubMed
1336286339Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds.Chemistry2023https://conductscience.org/library/papers/36286339PubMed
1427931243Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies.J Hematol Oncol2016https://conductscience.org/library/papers/27931243PubMed
1515560755Pimecrolimus -- an anti-inflammatory drug targeting the skin.Exp Dermatol2004https://conductscience.org/library/papers/15560755PubMed
1624446688Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor.J Med Chem2014https://conductscience.org/library/papers/24446688PubMed
1720739560Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice.J Neurosci2010https://conductscience.org/library/papers/20739560PubMed
1812815382The bicyclam AMD3100 story.Nat Rev Drug Discov2003https://conductscience.org/library/papers/12815382PubMed
1932274129Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study.J Thorac Dis2020https://conductscience.org/library/papers/32274129PubMed
2022543468Finding the sweet spot: the role of nature and nurture in medicinal chemistry.Nat Rev Drug Discov2012https://conductscience.org/library/papers/22543468PubMed

See all 183 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42819957All-Hydrocarbon Macrocycle Enables Highly Potent Th1-Biased NKT Cell Agonists for Immunotherapy.JACS Au2026https://conductscience.org/library/papers/42819957PubMed
42434599Computational QSAR and structure-based identification of plerixafor-derived PIM-1 kinase inhibitors in diffuse large B-Cell lymphoma.Front Chem2026https://conductscience.org/library/papers/42434599PubMed
41982728Synthesis and LCMS Characterization of a 1275-Member Library of 24-Atom Triazine Macrocycles Derived from Quantitative Dimerization Occurring with >99.9% Fidelity.ACS Med Chem Lett2026https://conductscience.org/library/papers/41982728PubMed
41746526Advancement in peptide-based therapeutics for the treatment of type 2 diabetes mellitus: current progress and future prospects.Mol Divers2026https://conductscience.org/library/papers/41746526PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40698129

GET https://conductscience.org/api/papers/v1/40698129/references?page=2